Mark W. Kieran, MD, PhD, director of Pediatric Medical Neuro-Oncology at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, spoke to pediatric patient families in a recent Facebook Live Webchat addressing pediatric brain tumor care. Kieran answered questions from audience members about the most common of the 300 brain tumor types that occur in children, including … Read more
At first, early intervention specialists told Christi Powers that her young son’s gross motor delays and poor balance were likely the result of weak muscle tone, but when Danny developed severe headaches at age 4, she took him to the emergency room. Soon the suburban Boston boy was diagnosed with a low-grade glioma, the most … Read more
Brain tumors can be among the most challenging cancers to treat. The blood-brain barrier, a natural defense mechanism that shields the brain from harm, can also prevent cancer treatments from reaching tumors. “It can be difficult to get treatments effectively into the brain,” says David Reardon, MD, clinical director of Dana-Farber’s Center for Neuro-Oncology. However, … Read more
The blood-brain barrier surrounds the brain and prevents harmful toxins and bacteria in the blood stream from entering the vital organ. What evolved as a life-saving defense, however, also blocks many drugs from reaching the brain, creating a major problem in treating brain tumors. The blood-brain barrier is formed by tightly-packed cells lining the walls … Read more
Childhood cancer is never easy for a family, and pediatric brain tumors can present a particularly difficult set of medical, cognitive, and physical challenges. Patients may face hearing and vision loss, seizures, learning disabilities, and more. Long after the disease is gone, these issues – and related emotional and social struggles – often remain. It … Read more
As one of the most difficult cancers to treat, childhood brain tumors are the leading cause of cancer-related deaths in children under age 10. However, researchers are making more progress than ever before. “Over the last 10 years there has been a lot of excitement about new treatments for pediatric brain tumors,” says Peter Manley, … Read more
By Eric Bender Multiple myeloma is a poster child for recent advances in treatment: In the past decade, the U.S. Food and Drug Administration (FDA) approved no fewer than nine treatments for the blood cancer, and several more drug approvals appear to be near. Not coincidentally, multiple myeloma is also a popular target that researchers … Read more
Eagerly awaited new data from trials of immunotherapy drugs, vaccines to treat brain tumors, and improved treatments for blood cancers sparked waves of optimism at the year’s biggest cancer meeting. The 2015 annual meeting of the American Society of Clinical Oncology (ASCO) drew about 30,000 cancer specialists to Chicago May 29 – June 2. Immunotherapy, … Read more
By Frannie Palmer As a kid, I stumbled on my feet quite a bit. I had to use two hands on the railing while going down stairs. My parents thought I was just a little clumsy. The truth was, a brain tumor was creating pressure on my cerebellum and causing my incoordination. I was 6-years-old … Read more
For many patients with brain tumors or other abnormal tissue located deep in the brain, treatment options have been limited. Last year, Jill Colter, now 50, discovered that a brain tumor resulting from Stage IV melanoma had returned. “Several years earlier, I had treatment with surgery and radiation, but the tumor came back,” Jill said. … Read more
Every year, about 4,700 children in the United States are diagnosed with brain cancer – making it the most common solid tumor in children. It is also one of the most difficult cancers to treat. Brain tumors are the leading cause of cancer-related deaths in children under age 10 and the second leading cause of … Read more
Highly malignant brain tumors called glioblastomas are the most common primary cancer of the brain; about 11,000 cases are diagnosed every year in the United States. Patrick Y. Wen, MD (Director) and David Reardon, MD, (Medical Director) of the Center for Neuro-Oncology at Dana-Farber/Brigham and Women’s Cancer Center describe the efforts to improve care for … Read more
Musician Sheryl Crow announced on June 5 that she has a benign brain tumor known as a meningioma. Below, doctors from Dana-Farber’s Center for Neuro-Oncology describe this condition. The singer-songwriter, a breast cancer survivor, visited Dana-Farber in 2006. Meningiomas are tumors on the surface of the brain, spinal cord, and fluid spaces. They are the … Read more
More than 600,000 people in the United States are living with a primary brain tumor — one that begins and stays in the brain — and over 60,000 adults and children will be diagnosed with a brain tumor this year. In recognition of May as Brain Tumor Awareness Month, we asked David Reardon, MD, clinical … Read more
Boston-based researchers hope to optimize CAR T-cell therapies to target DIPG, aggressive and difficult-to-treat brain tumors, and other tough-to-treat cancers.
Scientists’ main concern is that cell phones can increase the risk of brain tumors or other tumors in the head and neck area – and as of now, there doesn’t seem to be a clear answer.
Treatments used for many forms of cancer, as well as certain rare types of cancer that directly affect the ear(s), can affect your hearing. It’s important to understand the possibilities and know what to look for because, in some cases, early action can help. If you are affected by hearing loss, there are also resources … Read more
Certain forms of cancer and cancer treatment can affect your vision and, in rare cases, cause vision loss. At Dana-Farber, our care teams will work with you to help you understand the possibilities, know what to look for, and take action to manage any vision changes that might occur. What types of cancer can cause … Read more
Words like “chemobrain” and “chemofog” — terms now used by patients, doctors, and scientists to describe cognitive decline that some patients experience in response to cancer therapy — didn’t exist a few decades ago. Today, however, there’s a general awareness that cancer treatments can take a toll on the brain. Oncologists don’t yet have a … Read more